ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2025, Vol 15, No. 2

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of integrative fields within Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Why Publish with APB?

Free of charge publication for all article types
Fast and constructive peer review
Simple and efficient online submission
Author-friendly review process
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Original Research

1. Overexpression of Metastatic Related MicroRNAs, Mir-335 and Mir-10b, by Staphylococcal Enterotoxin B in the Metastatic Breast Cancer Cell Line

Mohammad Foad Heidary, Hamideh Mahmoodzadeh Hosseini, Elnaz Mehdizadeh Aghdam, Mohammad Reza Nourani, Reza Ranjbar, Reza Mirnejad, Abbas Ali Imani Fooladi*

Adv Pharm Bull. 2015;5(2): 255-259. doi: 10.15171/apb.2015.035

PMCID: PMC4517087 PMID: 26236665 Scopus ID: 84930400245

Article

PDF

XML

Cited By:

Research Article

2. Snail-1 Silencing by siRNA Inhibits Migration of TE-8 Esophageal Cancer Cells Through Downregulation of Metastasis-Related Genes

Maryam Hemmatzadeh , Hamed Mohammadi , Farhad Babaie , Mehdi Yousefi , Mehrdad Ebrazeh , Behzad Mansoori , Dariush Shanehbandi , Behzad Baradaran*

Adv Pharm Bull. 2018;8(3): 437-445. doi: 10.15171/apb.2018.051

PMCID: PMC6156482 PMID: 30276140 Scopus ID: 85052574262

Article

PDF

XML

Cited By:

Review Article

3. Lipid Drug Carriers for Cancer Therapeutics: An Insight into Lymphatic Targeting, P-gp, CYP3A4 Modulation and Bioavailability Enhancement

Shashank Chaturvedi* , Anurag Verma , Vikas Anand Saharan

Adv Pharm Bull. 2020;10(4): 524-541. doi: 10.34172/apb.2020.064

PMCID: PMC7539309 PMID: 33072532 Scopus ID: 85090468281

Article

PDF

Full Text

XML

Cited By:

Research Article

4. The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells

Edy Meiyanto* , Ulfatul Husnaa, Ria Fajarwati Kastian , Herwandhani Putri, Yonika Arum Larasati , Annisa Khumaira, Dyaningtyas Dewi Putri Pamungkas, Riris Istighfari Jenie , Masashi Kawaichi, Beni Lestari , Takashi Yokoyama, Jun-ya Kato

Adv Pharm Bull. 2021;11(1): 188-196. doi: 10.34172/apb.2021.020

PMCID: PMC7961225 PMID: 33747866 Scopus ID: 85094570870

Article

PDF

Full Text

XML

Cited By:

Mini Review

5. Cytobiological Alterations Induced by Celecoxib as an Anticancer Agent for Breast and Metastatic Breast Cancer

Maher Monir. Akl* , Amr Ahmed

Adv Pharm Bull. 2024;14(3): 604-612. doi: 10.34172/apb.2024.055

PMCID: PMC11530885 PMID: 39494258

Article

PDF

Full Text

XML

Cited By:

Original Article

6. Silencing Calumenin Expression via Artificial MicroRNA, a Potential Breakthrough for Inhibiting Proliferation, Halting Migration, and Triggering Apoptosis in Breast Cancer Cells

Zahra Amiri , Fatemeh Bahrami, Babak Jahangiri , Arash Javeri, Frouzandeh Mahjoubi, Nahid Nafissi, Mohammad Zaefizadeh, Fatemeh Masoumi, Alireza Zomorodipour*

Adv Pharm Bull. 2025;15(2): 453-466. doi: 10.34172/apb.025.43819

Article

PDF

XML

Cited By: